Axcelis Technologies (NASDAQ:ACLS) Stock Price Down 6.4% – Here’s What Happened

Axcelis Technologies, Inc. (NASDAQ:ACLS)’s share price fell 6.4% during mid-day trading on Wednesday . The stock traded as low as $125.50 and last traded at $126.74. Approximately 72,082 shares changed hands during trading, a decline of 89% from the average session volume of 680,530 shares. The stock had previously closed at $135.39.

Analysts Set New Price Targets

Several brokerages have weighed in on ACLS. Craig Hallum cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a research note on Friday, August 7th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axcelis Technologies in a report on Friday, August 7th. Finally, Bank of America boosted their price target on shares of Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a report on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $132.20.

Axcelis Technologies Trading Down 5.7%

The firm has a fifty day simple moving average of $149.98 and a two-hundred day simple moving average of $126.89. The firm has a market capitalization of $3.94 billion, a P/E ratio of 42.84, a price-to-earnings-growth ratio of 4.51 and a beta of 1.92. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21.

Axcelis Technologies (NASDAQ:ACLS) last issued its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The firm had revenue of $215.18 million during the quarter, compared to analyst estimates of $205.03 million. During the same quarter last year, the business earned $1.13 earnings per share. The company’s quarterly revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. On average, equities research analysts anticipate that Axcelis Technologies, Inc. will post 3.21 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Gerald M. Blumenstock sold 1,161 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $152.70, for a total transaction of $177,284.70. Following the completion of the transaction, the executive vice president directly owned 20,493 shares in the company, valued at $3,129,281.10. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Eileen Evans sold 926 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $155.51, for a total value of $144,002.26. Following the completion of the sale, the executive vice president directly owned 31,295 shares in the company, valued at approximately $4,866,685.45. The trade was a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 5,673 shares of company stock worth $890,967. Company insiders own 0.49% of the company’s stock.

Hedge Funds Weigh In On Axcelis Technologies

A number of institutional investors have recently made changes to their positions in ACLS. Royal Bank of Canada raised its holdings in shares of Axcelis Technologies by 3.8% during the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after buying an additional 4,324 shares in the last quarter. AQR Capital Management LLC boosted its position in Axcelis Technologies by 4.9% during the first quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after buying an additional 1,678 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Axcelis Technologies by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock valued at $963,000 after buying an additional 849 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Axcelis Technologies by 7.5% during the first quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after buying an additional 44,275 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Axcelis Technologies by 1.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock worth $3,912,000 after buying an additional 836 shares during the period. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.